Clinical Trials Logo

Peripheral Artery Disease clinical trials

View clinical trials related to Peripheral Artery Disease.

Filter by:

NCT ID: NCT05415995 Recruiting - Clinical trials for Peripheral Artery Disease

A Trail of Drug-coated Balloon Treating Below The Knee Arterial Diseases

Start date: March 1, 2022
Phase: N/A
Study type: Interventional

This is a prospective, multicenter, randomized controlled trail using drug-coated balloon to treat below the knee arterial stenosis or occlusion.

NCT ID: NCT05048979 Recruiting - Clinical trials for Peripheral Artery Disease

Telehealth to Improve Functional Status and Quality of Life in Veterans With PAD

MOVE-IT
Start date: December 1, 2021
Phase: N/A
Study type: Interventional

The present study aims to increase Veteran access to supervised exercise therapy and expand its role in improving functional status, quality of life, and cardiovascular risk profile of Veterans with PAD.

NCT ID: NCT04982367 Recruiting - Clinical trials for Peripheral Artery Disease

Acoart SCB SFA: Sirolimus Coated Balloon Catheter in the Treatment of Femoropopliteal Artery Stenosis

Start date: December 8, 2021
Phase: N/A
Study type: Interventional

A prospective randomized trial designed to compare the efficacy and safety of Sirolimus coated balloon (SCB) versus paclitaxel coated balloon (DCB) in the treatment of femoropopliteal artery stenosis

NCT ID: NCT04907240 Recruiting - Clinical trials for Peripheral Artery Disease

Observational GORE® VIABAHN® Endoprosthesis With PROPATEN Bioactive Surface Global Registry

Start date: October 9, 2021
Phase:
Study type: Observational [Patient Registry]

Collect real-world post-market clinical follow-up data on patients treated with the GORE® VIABAHN® Endoprosthesis with PROPATEN Bioactive Surface (VSX)

NCT ID: NCT04903912 Recruiting - Clinical trials for Peripheral Artery Disease

Campania Registry On Peripheral Artery Disease

CARE-PAD
Start date: May 1, 2021
Phase:
Study type: Observational [Patient Registry]

The CAmpania REgistry on Peripheral Artery Disease (CARE-PAD) is a single-center observational study which has the purpose to collect clinical, laboratory, instrumental, procedural and follow-up data and to evaluate the outcome of peripheral artery disease (PAD) patients.

NCT ID: NCT04889105 Recruiting - Clinical trials for Peripheral Artery Disease

Exercise Therapy for PAD Using Mobile Health

Smart MOVE
Start date: December 1, 2021
Phase: N/A
Study type: Interventional

Peripheral artery disease (PAD) is a highly prevalent condition affecting up to 10% of Veterans that leads to loss of walking ability and increased risk of amputation. Veterans have limited access to supervised exercise therapy, a facility-based program proven to improve walking ability in PAD, which is poorly attended due to the inconvenience and cost of attending a 12-week program with multiple weekly sessions. This CDA-2 application will investigate the feasibility of home-based exercise therapy (HBET) delivered using mobile health (mHealth) technologies in Veterans with symptomatic PAD. We will partner with the MOVE! program to deliver HBET through group behavioral coaching and a novel wearable activity monitor in a newly proposed program called Smart MOVE!. There is a clear need to provide effective and convenient alternatives to supervised exercise for Veterans with PAD. This study will provide evidence to proceed with Smart MOVE!, a much-needed patient-centered rehabilitation program for Veterans with PAD.

NCT ID: NCT04885985 Recruiting - Clinical trials for Peripheral Artery Disease

ACOART BTK RENEW:A Post Market Clinical Study

Start date: December 31, 2021
Phase: N/A
Study type: Interventional

The objective of this prospective, multi-center, single arm study is to obtain further data on the safety and performance of the Acotec Litos&Tulip Drug-coated Balloon catheters in the treatment of lesions in below-the-knee artery.

NCT ID: NCT04800692 Recruiting - Clinical trials for Peripheral Artery Disease

The Effects of ATLAS Therapy on Nitric Oxide Bioavailability in Patients With Intermittent Claudication

ATLAS
Start date: June 15, 2021
Phase: Phase 1
Study type: Interventional

This study will focus on people with claudication from peripheral arterial disease. The investigators are researching whether a multicomponent therapeutic can increase the production of Nitric Oxide in the blood and whether that leads to an improvement in pain free walking distance and overall physical activity.

NCT ID: NCT04794530 Recruiting - Clinical trials for Peripheral Artery Disease

The COCOA-PAD II Trial

COCOA-PAD II
Start date: November 19, 2021
Phase: Phase 3
Study type: Interventional

Among people with peripheral artery disease (PAD) age 55 and older, the investigators will test the hypothesis that PAD participants randomized to cocoa flavanols will have greater improvement or less decline in six-minute walk distance at six-month follow-up, compared to those randomized to placebo. The study will randomize 190 participants with PAD age 55 and older to one of two groups for six months: cocoa flavanols vs placebo. Our primary outcome is change in six-minute walk distance at six-month follow-up. Secondary outcomes are Actigraph-measured physical activity, brachial artery flow-mediated dilation (FMD), gastrocnemius muscle biopsy measures of endothelial nitric oxide synthase (eNOS) and phosphorylated eNOS, gastrocnemius muscle perfusion (measured by magnetic resonance imaging (MRI)) and gastrocnemius muscle characteristics (measured by muscle biopsy). To achieve the specific aims, the study will randomize 190 participants age 55 and older with PAD to one of two groups: cocoa flavanols vs placebo. Participants will be followed for six months.

NCT ID: NCT04772300 Recruiting - Clinical trials for Peripheral Artery Disease

Trial to Assess the Safety and Efficacy of Sirolimus-Coated Balloon vs. Uncoated Standard Angioplasty for the Treatment of Below-the-knee Peripheral Arterial Disease

LIMES
Start date: February 10, 2022
Phase: N/A
Study type: Interventional

This study is a prospective, interventional, multicenter 1:1 randomized trial. The trial evaluates the safety and efficacy of the Magic Touch PTA sirolimus drug-coated balloon in comparison to the treatment with POBA (control device) in patients with advanced infrapopliteal artery disease.